JohnJosephNemunaitisMD

Clinical Trials

• Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

  Unknown status

  Phase 3

• Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

  Unknown status

  Phase 3

• Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01

  Unknown status

  Phase 1

• Safety Study of Infusion of SGT-53 to Treat Solid Tumors Start of enrollment: 2008 Feb 01

  Completed

  Phase 1

• Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions Start of enrollment: 2009 Aug 01

  Completed

  Phase 1

• Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies Start of enrollment: 2009 Dec 01

  Completed

  Phase 1

• Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01

  Terminated

  Phase 3

• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01

  Terminated

  Phase 2, Phase 3

• A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers Start of enrollment: 2011 Oct 01

  Completed

  Phase 1

• Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer Start of enrollment: 2012 May 01

  Completed

  Phase 1

• Phase 1 Study of ONT-10 in Patients With Solid Tumors Start of enrollment: 2013 Mar 01

  Completed

  Phase 1

• Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors Start of enrollment: 2012 Sep 01

  Suspended

  Phase 1, Phase 2

• Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Start of enrollment: 2012 Feb 27

  Completed

  Phase 1, Phase 2

• CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext) Start of enrollment: 2012 Jul 03

  Completed

  Phase 2

• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) Start of enrollment: 2012 Dec 01

  Completed

  Phase 2

• Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma Start of enrollment: 2013 Jan 01

  Completed

  Phase 2

• A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast Cancer Start of enrollment: 2013 Dec 31

  Completed

  Phase 1

• A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer Start of enrollment: 2014 Jul 01

  Terminated

  Phase 2

• RTA 408 Capsules in Patients With Melanoma - REVEAL Start of enrollment: 2014 Oct 31

  Completed

  Phase 1, Phase 2

• OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure Start of enrollment: 2016 Feb 12

  Terminated

  Phase 3

• Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer Start of enrollment: 2017 Mar 23

  Terminated

  Phase 1

• Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors Start of enrollment: 2019 Jun 05

  Recruiting

  Phase 1

• Join now to see all